Changes in the lymphocyte subset after double-filtration plasmapheresis

American Journal of Clinical Pathology

Volumn 128, Issue 6, 2007, Pages 940-944

  Yeh, Jiann Horng ^a,b   Chien, Pei Ju ^c   Hsueh, Yu Mei ^c   Shih, Chwen Ming ^d   Chiu, Hou Chang ^a,b  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Double filtration plasmapheresis; Flow cytometry; Lymphocyte subset

Indexed keywords

ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CELL COUNT; CELLULAR IMMUNITY; FEMALE; GROUPS BY AGE; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; NORMAL HUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; SEX DIFFERENCE; SUPPRESSOR CELL; T LYMPHOCYTE; ADULT; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; LEUKOCYTE COUNT; MIDDLE AGED;

ADULT; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; LEUKOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PLASMAPHERESIS;

EID: 38049051762     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/L0DG8YU2WE5DV58H     Document Type: Article

References (21)

1. Bosch T. Therapeutic apheresis: state of the art in the year 2005. Ther Apher Dial 2005;9:459-468.
2. Skeie GO, Apostolski S, Evoli A, et al. Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol. 2006;13:691-699.
3. Keegan M, Konig F, McClelland R, et al. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet. 2005;366:579-782.
4. Selset Aandahl G, Jacobsen CD, Rode L, et al. Preliminary experience with plasma exchange in patients with ulcerative colitis. Transfusion Sci. 2000;22:155-160.
5. Furutama D, Nakajima H, Shinoda K, et al. Lymphocytapheresis in combination with immunosuppressive drugs for refractory myasthenia gravis: two-color flow cytometric analysis of changes in peripheral blood lymphocyte subsets. Eur Neurol. 1995;35:270-275.
6. Dau PC, Callahan JP. Immune modulation during treatment of systemic sclerosis with plasmapheresis and immunosuppressive drugs. Clin Immunol Immunopathol. 1994;70:159-165.
7. Dau PC. Immunomodulation during treatment of polymyositis with plasmapheresis and immunosuppressive drugs. J Clin Apheresis. 1994;9:21-25.
8. Ginsburg DS, Dau P. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis. Clin Nephrol. 1997;48:282-287.
9. Hanly JG, Hong C, Zayed E, et al. Immunomodulating effects of synchronised plasmapheresis and intravenous bolus cyclophosphamide in systemic lupus erythematosus. Lupus. 1995;4:457-463.
10. Yoshii F, Shinohara Y. Natural killer cells in patients with Guillain-Barré syndrome. J Neurol Sci. 1998;157:175-178.
11. Agishi T, Kancko I, Hasuo Y, et al. Double filtration plasmapheresis. Trans Am Soc Artif Intern Organs. 1980;26:406-411.
12. Shiga Y, Fujihara K, Onodera H, et al. Complement activation as a cause of transient hypotension during plasmapheresis. Artif Organs. 1998;22:1067-1069.
13. Senhauser DA, Westphal RG, Bohman JE, et al. Immune system changes in cytapheresis donors. Transfusion. 1982;22:302-304.
14. Braine HG, Elfenbein GJ, Mellits ED. Peripheral blood lymphocyte numbers, lymphocyte proliferative responses in vitro, and serum immunoglobulins in regular hemapheresis donors. J Clin Apheresis. 1985;2:213-218.
15. Prior CR, Coghlan PJ, Hall JM, et al. In vitro study of immunologic changes in long-term cytapheresis donors. J Clin Apheresis. 1991;6:69-76.
16. Rinder CS, Mathew JP, Rinder HM, et al. Lymphocyte and monocyte subset changes during cardiopulmonary bypass: effects of aging and gender. J Lab Clin Med. 1997;129:592-602.
17. Nand S, Molokie R. Therapeutic plasmapheresis and protein A immunoadsorption in malignancy: a briel review. J Clin Apheresis. 1990;5:206-212.
18. Fennelly DW, Norton L, Sznol M, et al. A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for Hearing metastatic breast cancer. Cancer. 1995;75:2099-2102.
19. Nand S. Therapeutic apheresis in malignancy. Ther Apher. 1997;1:29-32.
20. Tani T, Numa K, Hanasawa K, et al. Blood purification therapy in cancer treatment. Ther Apher. 1998;2:182-184.
21. Schneidewind-Muller J, Winkler RE, Tiess M, et al. Changes in lymphocytic cluster distribution during extracorporeal immunoadsorption. Artif Organs. 2002;26:140-144.